P. Savy et al. / Bioorg. Med. Chem. Lett. 12 (2002) 981–983
983
duplexes involving oligonucleotides O-1 to O-7, this
decreased stabilty due to the presence of N-7-deazaade-
nine should be taken into account since it should be
observed whatever the nature of the base pair. Thus,
4. (a) Herdewijn, P. Liebigs Ann. 1996, 1337. (b) Herdewijn, P.
Biochem. Biophys. Acta 1999, 1489, 167.
5
. (a) Uhlman, E.; Peyman, A.; Breipohl, G.; Will, D. W.
Angew. Chem., Int. Ed. Engl. 1998, 37, 2797. (b) Nielsen, P.
Acc. Chem. Res. 1999, 32, 624.
6. (a) Wengel, J. Acc. Chem. Res. 1999, 32, 301. (b) Meld-
gaard, M.; Wengel, J. J. Chem. Soc., Perkin 1, 2000, 3539.
with sequences O-1 and O-2 the decreased ÁT found
m
ꢀ
ꢀ
to be 4 C and 6 C, respectively, is comparable to what
is observed with the unmodified target 12AG. Con-
versely, for the duplexes formed between 12AaG and
oligonucleotides O-3, O-4 and O-7 the variation of ÁTm
7
. Flanagan, W. M.; Wolf, J. J.; Olson, P.; Grant, D.; Lin, K.-
Y.; Wagner, R. W.; Matteucci, M. D. Proc. Natl. Acad. Sci.
U.S.A. 1999, 96, 3513.
ꢀ
ꢃ 13 C is higher than expected for a simple intrinsic
8. Our approach is to some extent reminiscent of the one
previously reported by Switzer who proposed to take advan-
tage of the p-stacking properties of adenine. See: Switzer, C.;
Prakash, T. P.; Ahn, Y. Bioorg. Med. Chem. Lett. 1996, 6, 815.
9. Blackburn, G. M.; Gait, M. J., Eds. Nucleic Acids in
Chemistry and Biology; IRL, Oxford, UK: 1990.
lost of stability due to N-7-deazaadenine replacement.
Considering all these results, we conclude that the pre-
sence of a bulky substituent (linker+thymine) at the C-
0
5
position of 2 -deoxyuridine 2 exerts a destabilising
effect on duplex formation. However, when nucleosides
are introduced blockwise the destabilisation is not
1
gaa, P. J. Chem. Soc., Chem. Commun. 1997, 167.
0. Saintome
´
, C.; Clivio, P.; Favre, A.; Fourrey, J.-L.; Lau-
2
cumulative as one could have expected. A reasonable
explanation can be suggested in the case of oligonu-
cleotides O-3, O-4 and O-7 with the contiguous thymine
moieties making favourable contacts, presumably by
means of p-stacking. Under these conditions, the con-
cerned residues might be pushed inside the major
groove of the double helix to escape hydrophobic inter-
actions and take advantage of hydrogen bonding with
the N-7 position of the complementary adenine.
1
1
1
1. Dreyer, G.; Dervan, P. B. Proc. Natl. Acad. Sci. U.S.A.
985, 82, 968.
2. (a) Saintome
´
, C.; Clivio, P.; Fourrey, J.-L.; Woisard, A.;
, C.;
Clivio, P.; Fourrey, J.-L.; Woisard, A.; Laugaa, P.; Favre, A.
Favre, A. Tetrahedron Lett. 1994, 35, 873. (b) Saintome
´
Tetrahedron 2000, 56, 1197.
1
3. Compound 5: To a mixture of nucleoside 4 (340mg, 0. 5
mmol) and N-1-thyminyl-2-acetic acid (116 mg, 0.6 mmol) in
DMF (15 mL) were added succesively N-hydroxy-
benzotriazole (110mg, .07 mmol) and EDC (140mg, .07
mmol). After 3 h, the solvent was evaporated and the residue
purified by flash silica gel chromatography, elution with
CH Cl /MeOH (2–10% MeOH) containing 1% Et N gave
At best, this interpretation is tentative and more
experimentation will be required to characterise the
nature of the interactions that we have discovered with
nucleoside 2 and, in particular, to delineate the role of
the spacer arm. However, at this stage, it becomes clear
that we are dealing with two types of antagonising
forces suggesting that the entropic contribution of the
linker outbalances the enthalpic gain due to bonding
and stacking interactions which finally induces a con-
siderable destabilisation of the duplexes. Further
endeavour in this domain will be directed at the con-
struction of a less penalising linker.
2
2
3
nucleoside 5 as a white foam (374 mg, 87%). FAB-MS m/z 817
+
1
(M+ Li) . H NMR (300 MHz, CDCl ): d 7.62 (s, 1H, H-6),
3
7.44–7.21 (m, 10H, H-arom and H-6 T), 6.86 (d, J=8.7 Hz,
0
4H, H-arom), 6.29 (t, J=6.6 Hz, 1H, H-1 ), 4.46 (m, 1H, H-
0
0
3
6
), 4.01 (m, 1H, H-4 ), 3.77 (s, 6H, 2ꢄOMe), 3.39–3.23 (m,
0
H, 2ꢄH-5 and 2ꢄN-CH
2
), 2.44–2.09 (m, 4H, 2ꢄCH
2
), 1.94
(
s, 3H, Me).
4. Compound 6: To a solution of nucleoside 5 (85 mg, 0.1
Cl (5 mL) was added N,N-diisopropylethyl-
1
mmol) in CH
2
2
amine (0.4 mL) and cyanoethyl diisopropylchlorophos-
phoramidite (0.2 mL). The solution was stirred at room
temperature for 0.5 h, treated with an aqueous solution of
sodium bicarbonate (2x2mL), dried over magnesium sulfate
and evaporated under reduced pressure. The oily residue was
purified by column chromatography over silica gel with hep-
Acknowledgements
tane/EtOAc (1/1 to 2/8) containing 1% Et
3
N to give phos-
): d
We thank the ‘Association pour la Recherche contre le
Cancer’ (ARC), the ‘Fondation pour la Recherche
Medicale’ (FRM) and MERT for financial support (to
´
P.S. and R.S.). We are grateful to Dr. M. Thomas for
oligonucleotide syntheses.
phoramidite 6 (93 mg, 88%). 31P NMR (243 MHz, CDCl
3
1
1
37.6–137.3.
5. Standard oligonucleotides were purchased from Euro-
gentec and modified oligonucleotides were synthesised on an
0
Applied Biosystem 392 DNA/RNA synthetiser. The 5 -dime-
thoxytrityl (DMT) protected oligomers were purified by
reversed-phase HPLC (Waters PrepPak Cartridge Delta-Pak
C18, 15 mm, 300 A, 25ꢄ100 mm) using a 30 min linear gra-
dient of solvent A [0.1 M triethylammonium acetate buffer
References and Notes
(
pH 7) containing 7% of CH CN] and solvent B (CH CN)
3 3
(
100:0 to 60:40). The DMT protecting group was finally
1
. Kool, E. T. Annu. Rev. Biomol. Struct. 2001, 30, 1.
cleaved by treatment with 80% aq AcOH for 1 h at room
temperature. The oligomers were precipitated using an acetate
buffer (pH 6.2)/EtOH solution and isolated after centrifuga-
2
(
. (a) Seemann, N. C. Curr. Opin. Struct. Biol. 1996, 6, 519.
b) Seemann, N. C. Trends Biotechnol. 1999, 17, 437.
3
4
. Lebedeva, I.; Stein, C. A. Ann. Rev. Pharm. Toxicol. 2001,
1, 403.
ꢀ
tion at 0 C for 15 min.